Neuropilins in the Context of Tumor Vasculature
Open Access
- 1 February 2019
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 20 (3) , 639
Abstract
Neuropilin-1 and Neuropilin-2 form a small family of plasma membrane spanning receptors originally identified by the binding of semaphorin and vascular endothelial growth factor. Having no cytosolic protein kinase domain, they function predominantly as co-receptors of other receptors for various ligands. As such, they critically modulate the signaling of various receptor tyrosine kinases, integrins, and other molecules involved in the regulation of physiological and pathological angiogenic processes. This review highlights the diverse neuropilin ligands and interacting partners on endothelial cells, which are relevant in the context of the tumor vasculature and the tumor microenvironment. In addition to tumor cells, the latter contains cancer-associated fibroblasts, immune cells, and endothelial cells. Based on the prevalent neuropilin-mediated interactions, the suitability of various neuropilin-targeted substances for influencing tumor angiogenesis as a possible building block of a tumor therapy is discussed.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (SFB1009 A09)
This publication has 400 references indexed in Scilit:
- Vessel co‐option in primary human tumors and metastases: an obstacle to effective anti‐angiogenic treatment?Cancer Medicine, 2013
- GLI1 regulates a novel neuropilin‐2/α6β1 integrin based autocrine pathway that contributes to breast cancer initiationEMBO Molecular Medicine, 2013
- Recent Developments in Myofibroblast BiologyThe American Journal of Pathology, 2012
- Advances in light-based imaging of three-dimensional cellular ultrastructureCurrent Opinion in Cell Biology, 2012
- Oncogene addiction as a foundational rationale for targeted anti‐cancer therapy: promises and perilsEMBO Molecular Medicine, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Emerging roles of PDGF-D signaling pathway in tumor development and progressionBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- VEGF Receptor 2 Endocytic Trafficking Regulates Arterial MorphogenesisDevelopmental Cell, 2010
- Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression/function in breast tumor cellsBreast Cancer Research and Treatment, 2008
- VEGF165 mediates formation of complexes containing VEGFR‐2 and neuropilin‐1 that enhance VEGF165‐receptor bindingJournal of Cellular Biochemistry, 2002